Dudediligence.

Indivior Pharmaceuticals, Inc

INDVNASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 3013GPassive stake of 5% or more (13G), filed by Millennium Management
  2. Sep 178-KRegulation FD disclosure and other events7.018.019.01
  3. Sep 158-KEnd of a material agreement1.029.01
  4. Sep 11424B3Prospectus for an offering
  5. Aug 310-QQuarterly report
  6. Aug 38-KRegulation FD disclosure7.019.01
  7. Aug 38-KResults of operations and Regulation FD disclosure2.027.019.01
  8. Aug 38-KMaterial agreement and Regulation FD disclosure1.017.019.01
  9. May 158-KOfficer or director change and shareholder vote5.025.07
  10. May 48-KRegulation FD disclosure and other events7.018.019.01
  11. Apr 3010-QQuarterly report
  12. Apr 308-KResults of operations and Regulation FD disclosure2.027.019.01
  13. Mar 178-KMaterial agreement and unregistered sale of shares1.011.022.033.029.01
  14. Mar 138-KOther events8.019.01
  15. Mar 128-KOther events8.019.01
  16. Feb 2610-KAnnual report
  17. Feb 268-KResults of operations and Regulation FD disclosure2.027.019.01
  18. Jan 268-KMaterial agreement and unregistered sale of shares1.012.033.023.035.015.025.035.057.018.019.01
  19. Jan 88-KRegulation FD disclosure7.019.01
  20. Dec 22, 20258-KRegulation FD disclosure7.019.01
  21. Dec 18, 20258-KOfficer or director change5.02
  22. Dec 15, 20258-KBylaws or fiscal year changed and shareholder vote5.035.079.01
  23. Nov 20, 20258-KRegulation FD disclosure and end of a material agreement1.027.019.01
  24. Nov 14, 20258-KRegulation FD disclosure7.019.01
  25. Oct 30, 20258-K/AExit or restructuring costs (amended)2.05
  26. Oct 30, 202510-QQuarterly report
  27. Oct 30, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  28. Oct 1, 20258-KRegulation FD disclosure7.019.01
  29. Aug 26, 20258-KExit or restructuring costs2.05
  30. Aug 22, 20258-KOfficer or director change5.029.01
  31. Aug 4, 20258-K/AOfficer or director change (amended)5.02
  32. Jul 31, 202510-QQuarterly report
  33. Jul 31, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
  34. Jun 30, 20258-KRegulation FD disclosure7.019.01
  35. Jun 24, 20258-KOfficer or director change and other events5.028.019.01
  36. Jun 2, 20258-KRegulation FD disclosure7.019.01
  37. May 30, 20258-KOther events8.019.01
  38. May 9, 20258-K/AShareholder vote (amended)5.079.01
  39. May 8, 20258-KOfficer or director change and bylaws or fiscal year changed5.025.035.077.019.01
  40. May 1, 202510-QQuarterly report
  41. Apr 24, 20258-KResults of operations2.029.01
  42. Mar 27, 20258-KRegulation FD disclosure7.019.01
  43. Mar 4, 20258-KMaterial agreement and officer or director change1.015.029.01
  44. Mar 3, 202510-KAnnual report
  45. Mar 3, 20256-KReport from a foreign issuer
  46. Feb 28, 20256-KReport from a foreign issuer
  47. Feb 28, 20256-KReport from a foreign issuer
  48. Feb 28, 20256-KReport from a foreign issuer
  49. Feb 27, 20256-KReport from a foreign issuer
  50. Feb 27, 20256-KReport from a foreign issuer